We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$9.04B
AUM Growth
+$2.19B
Cap. Flow
+$1.88B
Cap. Flow %
20.78%
Top 10 Hldgs %
34.88%
Holding
3,092
New
1,032
Increased
581
Reduced
587
Closed
820

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$435M
2
AMZN icon
Amazon
AMZN
+$334M
3
MRNA icon
Moderna
MRNA
+$53.9M
4
LIN icon
Linde
LIN
+$44.2M
5
DTE icon
DTE Energy
DTE
+$43.5M

Top Sells

Rank Stock Value
1
IWD icon
iShares Russell 1000 Value ETF
IWD
+$63.6M
2
CMCSA icon
Comcast
CMCSA
+$39.7M
3
EVRG icon
Evergy
EVRG
+$38.5M
4
PEG icon
Public Service Enterprise Group
PEG
+$38.4M
5
TECH icon
Bio-Techne
TECH
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 15.37%
2 Consumer Discretionary 10.36%
3 Financials 7.14%
4 Industrials 6.8%
5 Healthcare 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OPEN icon
2676
Opendoor
OPEN
$3.43B
– –
-35,491
Closed -$728K
OR icon
2677
OR Royalties Inc
OR
$6.76B
– –
-18,935
Closed -$209K
ORMP icon
2678
Oramed Pharmaceuticals
ORMP
$200M
– –
-52,486
Closed -$533K
OSIS icon
2679
OSI Systems
OSIS
$3.41B
– –
-2,166
Closed -$208K
OTLK icon
2680
Outlook Therapeutics
OTLK
$157M
– –
-7,095
Closed -$319K
OUST icon
2681
Ouster
OUST
$2.77B
– –
-12,229
Closed -$1.04M
OZK icon
2682
Bank OZK
OZK
$5.39B
– –
-8,063
Closed -$329K
PARR icon
2683
Par Pacific Holdings
PARR
$3.96B
– –
-251,034
Closed -$3.54M
PASG icon
2684
Passage Bio
PASG
$14.3M
– –
-698
Closed -$244K
PBA icon
2685
Pembina Pipeline
PBA
$28.3B
– –
-18,922
Closed -$546K
PBH icon
2686
Prestige Consumer Healthcare
PBH
$2.43B
– –
-19,369
Closed -$854K
PCG icon
2687
PG&E
PCG
$38.8B
– –
-1,457,988
Closed -$17.1M
PCT icon
2688
PureCycle Technologies
PCT
$1.37B
– –
-38,000
Closed -$969K
PERI icon
2689
Perion Network
PERI
$386M
– –
-13,205
Closed -$236K
PFF icon
2690
PUT
iShares Preferred and Income Securities ETF
PFF
$13.1B
– –
-300,000
Closed -$11.5M
PFG icon
2691
Principal Financial Group
PFG
$23.7B
– –
-8,647
Closed -$518K
PFLT icon
2692
PennantPark Floating Rate Capital
PFLT
$731M
– –
-81,062
Closed -$963K
PFS icon
2693
Provident Financial Services
PFS
$3.09B
– –
-37,279
Closed -$831K
PHAT icon
2694
Phathom Pharmaceuticals
PHAT
$718M
– –
-7,534
Closed -$283K
PHR icon
2695
Phreesia
PHR
$749M
– –
-14,526
Closed -$757K
PINS icon
2696
Pinterest
PINS
$13.3B
– –
-17,031
Closed -$1.26M
PIPR icon
2697
Piper Sandler
PIPR
$5.3B
– –
-18,808
Closed -$516K
PKOH icon
2698
Park-Ohio Holdings
PKOH
$662M
– –
-9,484
Closed -$299K
PLBY icon
2699
Playboy Inc
PLBY
$146M
– –
-10,701
Closed -$210K
PLMR icon
2700
Palomar
PLMR
$3.42B
– –
-13,904
Closed -$932K
106 107
108
109 110

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q2 2021 Portfolio in Review

As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.

  • Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
  • Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
  • Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
  • Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
  • Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
  • Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
  • Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.